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Abstract 
Purpose 
The diagnosis of hip osteoarthritis is subject to several uncertainties, especially in primary care. The 
aims of this study were to determine (i) the diagnostic accuracy of coding of hip osteoarthritis by 
primary care physicians in the UK Clinical Practice Research Datalink (CPRD), (ii) the relative influence 
of radiographic and clinical parameters on diagnostic accuracy, and (iii) the accuracy of the diagnosis 
date. 
 
Methods 
An extract of all patients aged over 65 years, with a Read code for hip osteoarthritis listed between 
January 1995 and December 2014, was obtained from CPRD.  A random sample was selected of 170 
participants.  A questionnaire concerning data in medical records on relevant clinical and radiographic 
criteria used to establish the diagnosis of hip osteoarthritis was distributed to primary care physicians 
of participants.  Using diagnostic criteria, we formulated thresholds for diagnosis based on clinical, 
radiographic and combined grounds.   
 
Results 
119 completed questionnaires were returned (70% response rate).  The positive predictive value (PPV) 
of hip osteoarthritis codes, based on radiological criteria, was 79.8%.  The PPV, based on clinical 
criteria, was 79.0%, with substantial but not complete overlap.  Overall 12% of diagnoses were not 
confirmed.  In 42% of cases, there was disparity between date of diagnosis in CPRD and the medical 
record.  Median difference in date was +/-425 days (interquartile range, 18-1448 days).  
 
Conclusions 
Despite the difficulties in reaching a diagnosis of hip osteoarthritis in primary care, CPRD Read codes 
have a sufficiently high PPV for most research uses. However, the accuracy of diagnosis date may not 
be as reliable. 
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Background 
Osteoarthritis of the hip is one of the most prevalent disabling musculoskeletal problems, affecting an 
estimated 11% of the population (2.46 million individuals) in England1.  The only effective treatment 
for end-stage disease is hip replacement2: one of the most commonly performed elective surgical 
procedures in the elderly.  Expenditure in the USA alone on hip replacement was estimated to be $15 
billion/year3. 
 
Patients with hip osteoarthritis experience pain across a wide region in the ‘bathing trunk’ area, 
although patterns of pain differ and many also present with stiffness, difficulty in moving and joint 
swelling4. The diagnosis is normally confirmed by imaging, typically based on finding evidence of 
osteophytes, joint space narrowing and sclerosis on plain radiographic films.  Such findings at any 
grade are frequent in elderly individuals, and the threshold for the presence of significant disease is 
based on the Kellgren-Lawrence (K-L) grading system5. Given the high population prevalence of 
radiographic abnormalities, the clinical importance of the disorder rests on its impact on patients.  
Thus, non-radiographic features alone have  been considered as sufficient for use by the American 
College of Rheumatology (ACR) for hospital rheumatologists  and by the UK National Institute of 
Clinical Excellence (NICE) for primary care practitioners 6,7.   
 
Making a diagnosis of hip osteoarthritis in primary care is challenging for a number of reasons.  Firstly, 
the clinical presentation varies8.  Pain arising from the arthritic hip is difficult to differentiate because 
pain arising from other structures within the ‘bathing trunk’ area and because pain may be referred 
to different locations9.  Secondly, there is only a weak correlation between symptomatic disease and 
the radiographic severity 10,11.  Thirdly, there is no single best radiographic definition of what 
constitutes a ‘case.  A recent systematic review found studies had interpreted the K-L grading system 
differently, due to the inexact wording in the original system12.  There is no consensus on the threshold 
of joint space width for defining osteoarthritis, with values ranging from <1.5 to <4mm13–16.   
 
There may be a long lag between first presentation with symptoms and the diagnosis7.  It is unknown 
when in the course of a ‘patient journey’ with hip pain, is the diagnosis of osteoarthritis made in 
primary care.  
 
There is, thus, a need to interrogate large population primary care databases for hip osteoarthritis, to 
understand the current and future demands for hip joint replacement.  Indeed, electronic health 
records (EHR) provide an excellent resource because they offer a large cohort size, extensive 
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demographic and comorbidity information, and data on long-term outcomes.  However, the validity 
of such studies relies on the accuracy of the computerised codes.  We are not aware of any study 
which has investigated the validity of the diagnosis of hip osteoarthritis within primary care records.  
This is of particular relevance given the substantial issues leading to variation in practice in the 
diagnosis.  
 
This study therefore set out to examine the validity of the recorded diagnoses of hip osteoarthritis in 
UK electronic primary care records.  Specifically, we aimed to determine (i) the positive predictive 
value of EHR codes to identify ‘true cases’ of hip osteoarthritis, (ii) the relative influence of 
radiographic and clinical parameters on diagnostic recording, and (iii) the potential for error in using 
electronic recorded date of diagnosis. 
 
Methods 
Data set 
The Clinical Practice Research Datalink (CPRD) is a UK electronic database of anonymised longitudinal 
medical records from primary care17.  The data comprise approximately 14 million patient records of 
whom around 5.4 million are currently alive and registered at 660 primary care practices throughout 
the UK18.  Records are stored via Read codes and contain detailed clinical information on symptoms, 
diagnoses, investigations, prescriptions and hospital referrals, as well as basic sociodemographic 
characteristics as entered by the GP.  Read codes are a hierarchical clinical coding system of over 80 
000 terms that are used in general practice in the UK19.  Further descriptions of CPRD are published 
elsewhere20,21.  The study population consisted of a random sample of the 34656 living individuals 
registered in CPRD, aged >65 years, with a GP coded diagnosis of hip osteoarthritis made between 1 
January 1995 and 31 December 2014, and with a minimum one year of data being available before 
the date of diagnosis.  The Read codes for hip osteoarthritis are shown in Appendix I.  
 
Study design 
The accuracy of the hip osteoarthritis diagnosis was assessed in a random sample of the study 
population by questionnaire survey seeking clinical and radiographic information recorded in the 
patient’s medical records.  The questionnaire was mailed by CPRD to the GP of each patient in the 
sample.  This study was approved by the Independent Scientific Advisory Committee for MHRSA 
database research (ISAC protocol 17_024R). 
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The questionnaire incorporated items that would allow (i) a radiographic diagnosis and (ii) a clinical 
diagnosis based broadly on the radiographic and clinical features described in the K-L, ACR and NICE 
diagnostic schemes.  The questionnaire first sought concordance between the CPRD and the GP 
record, with a specific question on whether the GP patient record had ever had a diagnosis of hip 
osteoarthritis noted. If so, the questionnaire asked for (i) the date of diagnosis, (ii) whether the 
diagnosis was confirmed in secondary care, (ii) whether the diagnosis was subsequently revised.  The 
second set of questions focussed on the presence or absence of the specific items used to make the 
diagnosis.  The questions covered symptoms reported by the patient, findings from physical 
examination, and results from any hip radiographs that were recorded prior to the diagnosis of hip 
osteoarthritis.  The questionnaire is shown in Appendix II.  A returned questionnaire was considered 
invalid if it was returned blank. 
 
Sample size 
The study population size was determined by a sample size calculation.  To demonstrate sufficient 
validity, we proposed a PPV of 70% or greater would be required.  Based on previous CPRD validation 
studies for other diagnoses, that obtained additional information from GPs22, we predicted that 80% 
of cases would be confirmed as valid.  For the lower boundary of the 95% confidence interval of the 
proportion of valid cases to be above 70%, we calculated that we would need at least 85 returned 
questionnaires.  Based on previous CPRD validation studies, we predicted a questionnaire response 
rate of 50%, therefore 170 participants were randomly selected.  Participants were registered at 138 
GP practices (112 practices with 1 participant; 20 practices with 2 participants; 6 practices with 3 
participants). The GPs of the participants were mailed the questionnaire.  A period of three months 
for return of questionnaires was permitted before the study was ended. 
 
Data analysis 
We calculated response rate as the number of the returned valid questionnaires divided by total 
number of questionnaires sent.  One hypothesis is that the GPs who chose to return a completed 
questionnaire with clinical details that could be checked against their disease coding might be more 
confident in their diagnosis.  We therefore sought to determine what differences there might be 
between the patients for whom the GPs responded (‘responders’), compared to those patients whose 
GPs did not respond (‘non-responders’), to provide some indication of the background osteoarthritis 
risk in these two groups of patients.  An assessment of both participation bias (comparison of 
‘responders’ versus the whole CPRD cohort) and of non-response bias (comparison of ‘responders’ 
versus ‘non-responders’) was done by comparing age, gender, body mass index (BMI), socio-economic 
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status (SES) and comorbidities. SES was derived from the Index of Multiple Deprivation quintile of the 
GP practice region23. Comorbidities were scored with the Charlson Comorbidity Index24. 
 
An algorithm flow chart (Figure I) was used to make the diagnostic assignment of hip osteoarthritis.  
Cases were defined as radiologically confirmed cases of hip osteoarthritis if the report of radiographs 
reported evidence of ‘osteoarthritis’, ‘osteophytes’ or ‘joint space narrowing’.  Cases were defined as 
clinically confirmed cases if patients reported pain, stiffness or restriction of movement, or if physical 
examination found a reduced range of hip flexion or internal rotation.  Cases were defined as 
unconfirmed cases if these radiological or clinical parameters were not met.   
 
Patients could be classified as satisfying (i) radiographic criteria, (ii) clinical criteria, (iii) either 
radiographic or clinical criteria, and (iv) both radiographic and clinical criteria.  The PPV refers to the 
proportion of the cases that were confirmed as actual cases, based on the information provided by 
the GP in the questionnaire.  We calculated PPV as the number of confirmed cases divided by the total 
number of cases for whom a valid questionnaire was received from the patient’s GP.  Binomial 95% 
confidence intervals were calculated for the PPV.  In patients with a difference in the date of diagnosis 
recorded between CPRD and the GP patient record, the number of days between the two dates was 
calculated.  The distribution of the difference in date in those without an exact date match is displayed 
graphically.  
 
Results 
A total of 125 (73.5%) questionnaires were returned.  Six of the returned questionnaires were blank 
and therefore invalid, because GPs reported they could not access required data (in 5 cases GPs had 
changed computer software; in 1 case the patient was no longer registered at the practice), yielding 
a final response rate of 70.0% (119/170).  The response rate was higher amongst patients with a more 
recent diagnosis (date earlier/later than the median diagnosis date): 74% vs 66%. 
 
The comparison of demographic characteristics between the three populations of (i) the entire CPRD 
cohort with hip osteoarthritis, (ii) responders, and (iii) non-responders to the 170 questionnaires are 
shown in Table I.  The characteristics were broadly similar.  The non-responders were more likely to 
be male, but had very similar mean age, BMI and comorbidity status. Indeed, the responders had a 
socio-economic profile very close to the entire CPRD cohort with hip osteoarthritis.  
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In all, 95 of the 119 cases were confirmed based on radiological parameters, yielding a PPV of 79.8% 
(95% confidence interval (CI): 72.6%-87.0%), whilst 94 cases were confirmed based on clinical 
parameters, yielding a PPV of 79.0% (95% CI: 71.7%-86.3%).  The level of agreement between 
radiological and clinical confirmed cases is shown in Table II, with a Kappa statistic of 0.46, p value 
<0.001.  If either clinical or radiographic criteria were required to confirm diagnosis, the PPV was 
88.2% (95% CI, 82.4%-94.0%).  If both clinical and radiographic criteria were required to confirm 
diagnosis, the PPV fell to 70.5% (95% CI, 62.3%-78.7%).  
 
Of the 14 unconfirmed cases, in 12 cases there was no record of a diagnosis of osteoarthritis ever 
having been made. One case was unconfirmed because the diagnosis was subsequently changed to 
trochanteric bursitis.  One case was unconfirmed because radiological and clinical criteria were not 
met; however, the GP reported that the diagnosis of hip osteoarthritis was subsequently confirmed in 
secondary care. 
 
In 104 of the total 105 confirmed cases (99.0%) the date of diagnosis was recorded in the GP patient 
record. In the majority of cases (60/104), the date of diagnosis was identical to that on CPRD.  
However, in the other 44 cases (42.3%) there were discrepancies in diagnosis date in both directions; 
in the majority (32/44), the GP patient record recorded an earlier date of diagnosis than the CPRD 
record.  For many patients, there were substantial differences between the two dates (Figure II).  
Median difference in diagnosis date was +/-425 days (interquartile range, 18-1448 days). In only 11 
(26%) of patients was the difference less than 30 days; in others (24 cases) the difference extended to 
over 1 year, with 16 cases of earlier diagnosis in the GP patient record and 8 cases of earlier diagnosis 
in CPRD. 
 
Discussion 
The results of this validation study show that the diagnosis of hip osteoarthritis recorded in the CPRD 
has high PPV when assessed by radiological or clinical criteria (79.8% and 79.0% respectively).  These 
findings suggest that, using the criteria described here, the diagnosis of hip osteoarthritis in patients 
aged over 65 years made by GPs and recorded in the CPRD is accurate.  The level of accuracy of the 
diagnosis varied depending on the standard chosen; however, relying on radiological evidence or 
clinical evidence alone produced very similar rates.  By contrast caution should be taken in using the 
diagnosis date for research because the accuracy is mixed. 
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The presence of 12 CPRD hip osteoarthritis cases having no recorded diagnosis in the GP patient record 
was unexpected.  Possible explanations are that there was an error in completing the questionnaire 
by the GP, that the code was entered into CPRD in error, or that after diagnosis was made and 
recorded in CPRD, the GP subsequently edited the patient record.  Of note, one of the cases 
unconfirmed by radiological or clinical criteria but was reported to be confirmed in secondary care.  
The lack of evidence in the GP patient record to confirm the diagnosis may be because information 
was not passed back from secondary care to primary care.  Our analysis plan was to confirm cases 
based on defined radiological or clinical criteria, so this patient was treated in the analysis as an 
unconfirmed case because these criteria were not met.  Additionally, not all patients are seen in 
secondary care, so permitting the confirmation of diagnoses from secondary care would have 
introduced bias into our results.   
 
To our knowledge, no studies have previously investigated the PPV of hip osteoarthritis diagnosis in 
the CPRD dataset.  We identified one study that investigated the validity of osteoarthritis diagnoses 
recorded in health records in the British Colombia (Canada) Ministry of Health administrative 
database25.  They found that in patients diagnosed with knee osteoarthritis by one physician, the PPV 
of a valid diagnosis of knee, hip or hand osteoarthritis based on clinical criteria was 82% (95% CI, 71-
89%).  This is consistent with our findings. 
 
Selecting appropriate criteria to determine if a diagnosis of hip osteoarthritis is valid or not was 
fundamental.  Our approach to validate the diagnosis was based on the ways that the diagnosis of hip 
osteoarthritis is made in practice based on using both radiological and clinical information. 
 
Our approach to radiologically confirming the diagnosis allowed the presence of mention of 
‘osteoarthritis’ or of osteophytes or joint space narrowing as sufficient. The latter are the radiographic 
features required for K-L grading to radiologically define osteoarthritis.  We were unable to obtain the 
radiographs to formally K-L grade them and it was unlikely such grading would be available on routine 
GP records.  Our radiologically confirmed cases did not also require any further clinical evidence.  We 
believe this approach is justified because x-rays of the hip would most likely have been performed to 
investigate symptoms in the hip region.  However, it is possible that in some cases x-rays were 
performed for another clinical reason (for example, to investigate general surgical pathology), and 
that radiographic evidence of hip osteoarthritis was an incidental finding, leading to a diagnosis in the 
absence of clinical disease.  
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Our approach to clinically confirming the diagnosis of hip osteoarthritis, allowed the presence of 
mention of either pain, stiffness or restriction of movement, or reduced range of hip flexion or internal 
rotation as sufficient.  This differs from the NICE clinical diagnostic criteria. NICE require activity-
related joint pain and less than 30 minutes of morning stiffness in patients 45 years or over.  In this 
retrospective study, we took a pragmatic view, after discussing with primary care colleagues, that the 
quality of the data in routine records would not be of sufficient quality to allow robust assignment 
using criteria such as those of NICE or ACR. It was unlikely that there would be any accurate measure 
of, for example, range of hip flexion and internal rotation, these being good markers of hip 
osteoarthritis26. 
 
Thus, it is acknowledged that the basis for ‘proving’ the diagnosis of hip osteoarthritis from 
retrospective primary care records is limited by the available data.  In that context, it is considered 
that the PPV from radiographically confirmed cases is more valid. 
 
There was potential for bias between the quality of coding of GPs that responded and those that did 
not.  We have demonstrated that there were no significant differences between the patients based 
on age, gender, comorbidity or their GP practice index of multiple deprivation. Of note, the profile of 
social demographic status of responders closely mirrored the entire CPRD cohort.  However, we are 
unable to exclude the possibility that in some of the cases of unreturned questionnaires, GPs may 
have chosen to not respond on finding a lack of evidence to confirm the diagnosis of hip osteoarthritis. 
 
The sample size was sufficient to demonstrate that the diagnosis was valid using radiological and 
clinical parameters separately; however, a larger sample size would have enabled a more accurate 
PPV calculation, with a smaller 95% CI.  As with many validation studies, this study was limited by 
costs.  Costs were £35 for each questionnaire distributed by CPRD and £55 for each questionnaire 
returned by GPs.  The period for responses was limited to three months due to time constraints and 
because it was predicted that the majority of responses would be received within two months.  This 
transpired: 84% (105/125) returned questionnaires were returned within two months. 
 
We attempted to ensure that only incident cases of hip osteoarthritis during the study period were 
included.  Our approach to achieve this was to exclude patients for whom there was a mention of hip 
osteoarthritis in the 12 months prior to diagnosis in the CPRD system.  However, we cannot exclude 
the possibility that some of the patients in this analysis may have had a diagnosis of hip osteoarthritis 
previously.  This could occur in two ways.  Firstly, in the UK patients are free to move between different 
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primary care providers.  The CPRD database can only capture clinical events during the time when an 
individual patient is registered with a CPRD practice, and therefore some patients may have had a 
diagnosis of hip osteoarthritis previously in a non-CPRD practice.  Secondly, patients may have had a 
diagnosis of hip osteoarthritis in a CPRD practice more than one year previously and had not consulted 
their GP for at least a year.  On investigation of the date of diagnosis, we found 16 cases where the 
date of diagnosis in the GP patient was more than one year earlier than in the CPRD record.  These 16 
cases may represent cases where the date of diagnosis in CPRD was not accurate or prevalent cases 
where an earlier diagnosis was recorded in CPRD but was missed because we only investigated one 
year prior to the diagnosis within our study period.  Because of this uncertainty, we elected not to 
exclude these 16 cases. We believe it is unlikely that either scenario is likely to be of material impact 
to the results of the coding accuracy analysis.  However, were it possible to identify and exclude such 
patients, the disparity in date of diagnosis in CPRD and the GP patient record would likely be lower.” 
 
This study aimed to assess the accuracy of “new” diagnoses of hip osteoarthritis using the Read Codes 
provided by primary care practitioners on the CPRD database.  Although there are estimates of the 
point prevalence of hip osteoarthritis from population surveys, it was not possible for us to derive any 
comparative estimate of the prevalence of OA in the CPRD population, because our patient cohort 
only constituted new diagnoses in primary care.  Further studies may attempt to investigate the 
proportion of hip OA cases seen in UK primary care that are not diagnosed or coded by the GP, 
although this may prove challenging because there are no “gold-standard” data to compare primary 
care data with.  Indeed, there are studies from many disorders in the literature where CPRD itself has 
been used as such a gold-standard. 
 
A key limitation is that from our data we can calculate PPV of the diagnosis in CPRD, but not sensitivity.  
There may exist many cases of patients in the CPRD that have hip osteoarthritis but do not have it 
diagnosed or recorded.  It was not possible to identify these patients, thus a sensitivity calculation was 
not possible.  Future studies on hip osteoarthritis in the CPRD should consider this potential source of 
bias.  
 
It is also important to consider whether there were codes used by some primary care practitioners for 
registering cases of hip osteoarthritis that were not considered in this analysis.  For example, we did 
not include those codes that covered “osteoarthritis of the pelvic area” but had not mentioned hip.  It 
would be important in future studies to determine if such codes are widely used by some primary care 
practitioners for hip osteoarthritis. However, whilst our exclusion of considering such cases would 
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under-estimate the total number of hip OA patients, a plausible conclusion is that the levels of clinical 
and radiographic confirmation of such cases would not necessarily be different from those where the 
primary care practitioner preferred to use the term hip.  This however remains to be proven. 
 
The cohort of patients was restricted to patients aged over 65 years. This is because there is greater 
diagnostic uncertainty in patients aged under 65, and therefore more complex to validate.  The 
findings of this paper should not be assumed to apply to diagnoses of hip osteoarthritis made in 
younger patients. 
 
Conclusion 
In conclusion, the recorded diagnosis of hip osteoarthritis was confirmed in a high proportion of 
patients aged over 65 years within CPRD, and therefore Read codes for hip osteoarthritis amongst all 
patients aged over 65 in the CPRD dataset are likely to accurately identify true cases.  However, 
accurate diagnosis timing remains difficult to determine. 
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Table I: Demographic characteristics of patients aged >65 years with hip osteoarthritis recorded 
within CPRD, and responders and non-responders to the GP validation questionnaire 
 
  Entire cohort Responders Non-responders 
  Number % Number % Number % 
Cohort size 34, 656  119  51   
Gender           
   Male 14183 40.9 55 46.2 26 51.0 
   Female 20473 59.1 64 53.8 25 49.0 
Age (mean, SD) 75.2 11.5 73.7 11.7 74.3 11.4 
BMI (mean, SD) 28.4 5.3 28.6 5.1 28.5 6.2 
CCI (mean, SD) 0.36 0.95 0.40 0.93 0.35 1.05 
IMD           
   Quintile 1: Least 
deprived 
5688 26.4 17 27.4 5 20.8 
   Quintile 2 5342 24.8 14 22.6 7 29.2 
   Quintile 3 4664 21.6 12 19.4 1 4.2 
   Quintile 4 3756 17.4 13 21.0 8 33.3 
   Quintile 5: Most 
deprived 
2111 9.8 6 9.7 3 12.5 
   Missing 13095  - 57  - 27 -  
BMI: body mass index (kg/m2); CCI: Charlson Comorbidity Index; IMD: Practice level Index of 
Multiple Deprivation, 2004 
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Table II: Overlap of cases confirmed by radiological and clinical parameters 
 
  Clinical 
  Confirmed Unconfirmed All 
 Confirmed 84 (70.5%) 11 (9.2%) 95 (79.8%) 
Radiological  Unconfirmed 10 (8.4%) 14* (11.8%) 24 (20.2%) 
 All 94 (79.0%) 25 (21.0%) 119 (100%) 
Kappa statistic = 0.46, p value <0.001 
*One case was unconfirmed by radiological and clinical parameters; however, the GP reported that the 
case was confirmed in secondary care. 
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Figure I: Algorithms for diagnosis based on radiologic and clinical parameters, based on returned 
questionnaire answers 
(a) Algorithm for diagnosis based on radiologic parameters 
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(b) Algorithm for diagnosis based on clinical parameters  
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Figure II: Box and whisker plot of the time in years between dates, of patients with a different date of 
diagnosis between CPRD and GP patient record. (N=44). 
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Supplementary material 
 
Appendix 1: Read codes for hip osteoarthritis 
1. N053512 Hip osteoarthritis NOS 
2. N05z511 Hip osteoarthritis NOS 
3. N05zJ00 Osteoarthritis NOS, of hip 
4. Nyu2100 [X]Other primary coxarthrosis 
5. N051900 Primary coxarthrosis, bilateral 
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Appendix 2: Questionnaire  
 
Practice ID:  Vision Patient ID:  Sex:  Birth Year:  
 
 
 
Questionnaire into Validation of Hip Osteoarthritis 
 
1. Diagnosis 
 
a) Was the patient diagnosed with osteoarthritis of the hip? 
□ Yes 
If Yes, please provide the diagnosis date:    __ / __ / ____ 
□ No 
If No, no further responses to the questionnaire are required 
b) Was the diagnosis confirmed in secondary care? 
□ Yes 
□ No 
c) Was the diagnosis subsequently changed to an alternative diagnosis? 
□ Yes 
□ No 
 
2. Presentation 
 
a) Prior to the diagnosis of osteoarthritis of the hip, did the patient attend with any 
hip related symptoms? 
□ Yes 
□ No 
□ Unknown (If No or Unknown, please proceed to question 3) 
b) Please indicate which symptoms the patient complained of (Please tick all that 
apply): 
□ Pain  
□ Stiffness 
□ Restriction of movement 
□ Other (please indicate): __________________________________ 
 
3. Physical Examination 
 
According to the patient’s electronic healthcare record (including hospital letters), 
please indicate which best apply based on the last joint examination made prior to 
diagnosis or hip osteoarthritis (Please tick all that apply): 
 
□ Normal range of joint movement  
□ Reduced range of hip flexion 
□ Reduced range of hip internal rotation 
□ No record of joint examination 
 
4. Imaging Investigations 
 
According to the patient’s electronic healthcare record (including hospital letters), 
please indicate which apply based on hip or pelvis X-rays/scans taken prior to 
diagnosis of hip osteoarthritis (Please tick all that apply): 
 
□ Osteoarthritis 
□ Osteophytes 
□ Narrowing of hip joint space 
Many thanks for your time in completing this questionnaire. Please return it as soon 
as possible to the CPRD in the freepost envelope provided. 
